Navigation Links
Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community- Associated Methicillin Resistant Staphylococcus Aureus (CA-MRSA)
Date:6/25/2008

SA), and has rapidly become one of the most common causes of skin and soft tissue infections among otherwise healthy people in the community. Staphylococcus aureus and CA-MRSA are causative pathogens for respiratory tract infections such as community acquired pneumonia (CAP). The CA-MRSA strain can attack and destroy white blood cells that normally help fight infections and can be even more aggressive than the hospital associated MRSA infections. Although the early strains of CA-MRSA strains were susceptible to most antimicrobials, bacterial resistance has increased, creating a need for new antibiotics that can cover the emerging deadly CA-MRSA strain.

The aim of the study reported in the paper was to compare the antimicrobial activity of cethromycin with three other macrolides (azithromycin, clarithromcin and erythromycin) and one lincosamide (clindamycin) against the 170 MRSA USA300 isolates that are contained in the Center for Biological Defense collection at the University of South Florida.

Cethromycin was shown to be effective against all 170 isolates, achieving an MIC range of < / = 0.002-0.125 mg/L, whereas the MIC50 and MIC90 were both < / = 0.002 mg/L. In addition, cethromycin demonstrated a MBC range of < / = 0.002-1.0 mg/L, with the MBC50 of < / = 0.002 mg/L and the MBC90 of < / = 0.008 mg/L. Of the 170 CA-MRSA isolates, 169 (99.4%) were intermediate or resistant to at least one macrolide. In contrast, 164 (96.5%) isolates were susceptible to clindamycin. Only six (3.5%) isolates demonstrated either constitutive resistance [4 (2.4%)] or inducible resistance [2 (1.2%)] to clindamycin. Against 10 erythromycin-susceptible isolates, the cethromycin MIC and MBC ranges were < / = 0.002-0.008 mg/L, compared with the MIC range of < / = 0.002-0.25 mg/L and MBC range of < / = 0.002-1.0 mg/L obtained with the erythromycin-resistant isolates. MIC50 and MBC50 values, as well as MIC90 and MBC90 values, did not change regardless of erythromycin susceptibil
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
2. Adlyfe Study on the Detection of Misfolded Proteins Published in the Journal Transfusion
3. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
4. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
5. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
6. Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless, States SafeMinds
7. Risks Associated With Face Transplants May Be Lower Than Previously Thought, ASPS Journal Review Suggests
8. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
9. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
10. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
11. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... Minn. , June 30, 2015  EnteroMedics Inc. ... devices that use neuroblocking technology to treat obesity, metabolic ... its previously announced public offering  of 40,229,886 units. Each ... of a Series A warrant to purchase one share ... warrant to purchase one share of common stock, at ...
(Date:6/30/2015)... June 30, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... 2015 Annual Meeting of StockholdersWhen:Tuesday, June 30 at 5:10 ... the Internet.  Simply log onto our website listed above. ... during the live event, a replay of the webcast ... www.isispharm.com . ABOUT ISIS PHARMACEUTICALS, INC. ...
(Date:6/29/2015)... , June 29, 2015  Daktari Diagnostics was honored ... the Technology in the Service of Society Award. IEEE President ... Barry L. Shoop presented the award to Principal ... The ceremony was held Saturday, June 20, 2015, at the ... . "I have spent more than ...
Breaking Medicine Technology:EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 3Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 2Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 3Daktari Honored with IEEE Spectrum Award 2
... leading provider of medical scrubs, is now accepting nominations through ... . The award provides the nation an opportunity to recognize ... duty to make a difference for their patients and the ... 9,000 healthcare professionals have been nominated for the award. To ...
... 2011 Wako Diagnostics, a division of Wako Chemicals ... and Drug Administration (FDA) to market the uTASWako i30 ... in vitro diagnostic (IVD) tests in the ... use by healthcare professionals as an aid in the ...
Cached Medicine Technology:Cherokee Inspired Comfort Award Calls for Healthcare Professional Nominations 2Cherokee Inspired Comfort Award Calls for Healthcare Professional Nominations 3Announcing 510(k) Clearance of a New Microfluidic-based IVD Test System, the uTASWako® i30 Immunoanalyzer, and AFP-L3 and DCP Assays for Liver Cancer Risk Assessment. 2
(Date:6/30/2015)... EAGAN, Minn. (PRWEB) , ... June 30, 2015 , ... ... $1.5 million in funding for 24 projects across the state. The projects improve community ... Grants range from $25,000 to $100,000 and many are renewable for a second year ...
(Date:6/30/2015)... Ohio (PRWEB) , ... June 30, 2015 , ... ... services nationwide, is pleased to announce it’s own Debby Mann, CPC, RCC, ROCC, ... Association (RBMA) Radiology Summit with the Special Recognition Award for her contribution to ...
(Date:6/30/2015)... ... 30, 2015 , ... The LIV Fertility Center in Puerto Vallarta ... right age to pursue egg freezing. Statistics show that 20 percent of women are ... 150 percent increase since the 1970s. , Sadly, for women who have delayed parenthood ...
(Date:6/30/2015)... ... June 30, 2015 , ... The American Lung Association in ... media event in San Diego. Speakers and clean air advocates included San Diego County ... Germuska of Kindred Hospital, and Daniel Sullivan, founder and president of Sullivan Solar Power. ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... nationwide, announces today that they have been awarded the exclusive billing agreements with ... full range of billing services encompassing their proprietary suite of billing process software ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota Foundation Awards $1.5 Million 2Health News:ADVOCATE’s Debby Mann Honored With Special Recognition Award 2Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 2Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 3Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 4Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 5Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 2Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 3Health News:ADVOCATE Wins Billing Agreements with Jackson Radiology Associates 2
... , , , ... Los Angeles today announced that Caroline W. Nahas, managing director of ... the new volunteer chair of the organization,s corporate board of directors. ... served in this important role. Nahas will replace outgoing board chair, ...
... four sites across the country to participate in a new ... the effectiveness of a chemotherapeutic agent, ThermoDox, used in conjunction ... recurrent chest wall breast cancer. Recurrent chest wall ... the chest wall, most commonly presenting in the skin overlying ...
... ... tips on keeping kids healthy and active this summer , ... Minneapolis, MN (PRWEB) July 20, 2009 -- On soccer fields ... enjoy the summer sun. While the occasional bump or bruise is expected and normal, some ...
... , NAPERVILLE, Ill., July 20 The ... that Maryjane A. Wurth, 53, Chief Operating Officer, Healthcare Association of ... of IHA. Wurth succeeds Ken Robbins, who has served as IHA ... assume her duties as IHA,s president in October. , ...
... to view smoking-related content, study shows, , MONDAY, July 20 ... isn,t watching TV shows or movies that glamorize smoking, he ... the Internet, particularly from popular social networking sites such as ... 20 in Pediatrics , found that the Internet is ...
... , CAMP HILL, Pa., July 20 Highmark Blue Shield ... Health Conference, set for Saturday, Aug. 29 from 6:30 a.m. until 3 ... and University Drive in Hershey, Pa. , , ... a greater hand in their health by attending Fun, Fit & Fabulous! ...
Cached Medicine News:Health News:Caroline W. Nahas Named New Corporate Board Chair for United Way of Greater Los Angeles 2Health News:Caroline W. Nahas Named New Corporate Board Chair for United Way of Greater Los Angeles 3Health News:RI Hospital first in country to enroll patient in new study for recurrent chest wall breast cancer 2Health News:Treating Kids' Summertime Bumps, Bruises and Injuries with The Healthcare Scoop 2Health News:Treating Kids' Summertime Bumps, Bruises and Injuries with The Healthcare Scoop 3Health News:Maryjane A. Wurth Named New President of Illinois Hospital Association 2Health News:Internet May Be Newest Venue for Teen Tobacco Exposure 2Health News:Internet May Be Newest Venue for Teen Tobacco Exposure 3Health News:Feel Fun, Fit & Fabulous! At the 2009 Women's Health Conference 2Health News:Feel Fun, Fit & Fabulous! At the 2009 Women's Health Conference 3
The URCA (Uric acid) method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of uric acid in serum, plasma and urine....
For the quantitative in vitro determination of apolipoprotein A-1 (apo A-1) in serum and plasma. For use as an aid if assessing the risk of coronary artery disease....
The GGT method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of g-glutamyl transferase activity in serum and plasma...
For the quantitative in vitro determination of Triglycerides in serum and plasma....
Medicine Products: